ANVISA, Brazil

Director

Director of the Second Board
Term: 11/04/2020 to 12/12/2024

Serving Anvisa, she served as deputy director, general manager of Toxicology and manager of the medication area.

Academic graduation / title

2013 – Specialist in Pharmaceutical Technology – Faculdade Federal Fluminense;

2003- Improvement in clinical analysis – Faculty of Pharmacy, Federal University of Minas de Gerais;

2000 – PHARMACY – Qualification in Clinical Analysis – Faculty of Pharmacy, Federal University of Minas de Gerais

Professional performance:

National Health Surveillance Agency (Anvisa)

Dec/2020 – Current – Director – Second Board of Anvisa

Apr/2020 – Dec/2020 – Deputy Director – Fourth Board of Anvisa

Dec/2018 – Apr/2020- Deputy Director – Fourth Board of Anvisa

Jul/2018 – Dec/2018 – Deputy Director – Board of the National Health Surveillance System

Apr/2017 – Jul/2018 – Deputy Director – Authorization and Registration Board

Feb/2016 – Apr/2017 – General Manager of Toxicology

Aug/2016 – Dec/2016 – Deputy Director – Authorization and Registration Board

Jun/2014 – Feb/2016- Superintendent of Medicines and Biological Products – Substitute

Jun/2014 – Oct/2014- Drug Post-Registration Manager

May/2012 – Jun/2014 – Pharmaceutical Technology Manager – Substitute

Mar/2009 – Jun/2014 – Coordinator of the Post-Registration of Medicines Coordination

Mar/2007 – Mar/2009- Specialist in Regulation and Sanitary Surveillance at the General Management of Medicines

Centificalab Laboratory – Santa Casa de Misericórdia Hospital (2006 – 2007)

Function: Clinical analysis laboratory manager
Main responsibilities: People management; Cost and quality management

Drogaria Araújo S/A (2000 – 2003)

Function: Pharmacist – Technical Responsible

productions

Bibliographic production:

2013- Evaluation of stability studies of carbamazepine drugs registered until June 2013. (Improvement/Specialization in Specialization Course in Pharmaceutical Technology) – Universidade Federal Fluminense – UFF. COLLABORATION IN PUBLICATION

2007 – Clinical Protocol FHEMIG – Hospital management of tuberculosis – https://studylibpt.com/doc/1543647/caderno-de-protocolos-cl%C3%ADnicos-da-fhemig. Page 229 – 240

PARTICIPATION IN EVALUATION OF A SPECIALIZATION COURSE MONOGRAPH 6/6 – Discarding Medicines for Domestic Use -2011- Specialization Course in Health Surveillance – ANVISA/FIOCRUZ; – Microbiological quality control of non-sterile medicines- 2010- Specialization Course in Health Surveillance – ANVISA/FIOCRUZ;

 

Register for the Biosimilars LatAm – Brazil 2023

Back